« previous next »
Pages: [1]

Author Topic: (Abst.) Adverse event profile differences between Rituxan and Ocrevus...  (Read 94 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9549
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Adverse event profile differences between Rituxan and Ocrevus...
« on: August 24, 2020, 09:21:49 pm »
From Multiple Sclerosis Journal (August 24, 2020), "Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database":


https://journals.sagepub.com/doi/abs/10.1177/1352458520949986



Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9549
  • MS diagnosed 1980
  • Location: Pacific Northwest
(MS News Today) MS infection risk for Ocrevus higher than Rituxan but cancer risk lower
« Reply #1 on: August 26, 2020, 07:25:46 pm »
More on this in Multiple Sclerosis News Today (August 26, 2020)--"MS infection risk for Ocrevus higher than Rituximab but cancer risk lower":


https://bit.ly/2YDIxmm
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
190 Views 		Last post June 14, 2017, 10:35:24 am
by agate
0 Replies
72 Views 		Last post April 25, 2017, 01:07:23 pm
by agate
0 Replies
66 Views 		Last post October 05, 2019, 07:51:03 am
by agate
1 Replies
57 Views 		Last post May 03, 2021, 09:46:55 pm
by agate
0 Replies
31 Views 		Last post September 17, 2021, 08:18:27 pm
by agate